Clinical Trial Update: Thrombectomy Under Reopro Versus Alteplase to Treat Stoke [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing thrombectomy using abciximab (ReoPro) versus alteplase for middle cerebral artery ischemic stroke has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Middle Cerebral Artery Infarction
• Stroke

Drugs mentioned

• Activase (alteplase)
• ReoPro (abciximab)

Snippet

Sponsor: SOS Attaque Cérébrale | Conditions: Infarction, Middle Cerebral Artery | Phase 4 | Status: TERMINATED